Legionnaires’ disease in South Africa, 2012–2014
dc.contributor.author | Wolter, Nicole | |
dc.contributor.author | Carrim, Maimuna | |
dc.contributor.author | Cohen, Cheryl | |
dc.contributor.author | Tempia, Stefano | |
dc.contributor.author | Walaza, Sibongile | |
dc.contributor.author | Sahr, Philip | |
dc.contributor.author | De Gouveia, Linda | |
dc.contributor.author | Treurnicht, Florette | |
dc.contributor.author | Hellferscee, Orienka | |
dc.contributor.author | Cohen, Adam L. | |
dc.contributor.author | Benitez, Alvaro J. | |
dc.contributor.author | Dawood, Halima | |
dc.contributor.author | Variava, Ebrahim | |
dc.contributor.author | Winchell, Jonas M. | |
dc.contributor.author | Von Gottberg, Anne | |
dc.date.accessioned | 2016-05-16T06:29:41Z | |
dc.date.available | 2016-05-16T06:29:41Z | |
dc.date.issued | 2016-01 | |
dc.description.abstract | During June 2012–September 2014, we tested patients with severe respiratory illness for Legionella spp. infection and conducted a retrospective epidemiologic investigation. Of 1,805 patients tested, Legionella was detected in samples of 21 (1.2%); most were adults who had HIV or tuberculosis infections and were inappropriately treated for Legionella. | en_ZA |
dc.description.department | Immunology | en_ZA |
dc.description.librarian | am2016 | en_ZA |
dc.description.sponsorship | This work was supported by the National Health Laboratory Service, South Africa, and the US Centers for Disease Control and Prevention (CDC-RFA-GH12-00403). A. von G. received grants from the US Centers for Disease Control and Prevention and Pfizer-South Africa. H.D. received honoraria or travel grants from Merck Sharp & Dohme–South Africa; Novartis–South Africa; and Pfizer–South Africa. | en_ZA |
dc.description.uri | http://www.cdc.gov/eid | en_ZA |
dc.identifier.citation | Wolter, N, Carrim, M, Cohen, C, Tempia, S, Walaza, S, Sahr, P, De Gouveia, L, Treurnicht, F, Hellferscee, O, Cohen, AL, Benitez, AJ, Dawood, H, Variava, E, Winchell, JM & Von Gottberg, 2016, 'Legionnaires’ disease in South Africa, 2012–2014', Emerging Infectious Diseases, vol. 22, no. 1, pp. 131-133. | en_ZA |
dc.identifier.issn | 1080-6040 (print) | |
dc.identifier.issn | 1080-6059 (online) | |
dc.identifier.other | 10.3201/eid2201.150972 | |
dc.identifier.uri | http://hdl.handle.net/2263/52628 | |
dc.language.iso | en | en_ZA |
dc.publisher | Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention | en_ZA |
dc.rights | Coordinating Center for Infectious Diseases, Centers for Disease Control and Prevention | en_ZA |
dc.subject | Legionella | en_ZA |
dc.subject | Patients | en_ZA |
dc.subject | Infection | en_ZA |
dc.subject | Respiratory illness | en_ZA |
dc.subject | Tuberculosis (TB) | en_ZA |
dc.subject | Human immunodeficiency virus (HIV) | en_ZA |
dc.subject | Legionnaires’ disease | en_ZA |
dc.subject | South Africa (SA) | en_ZA |
dc.title | Legionnaires’ disease in South Africa, 2012–2014 | en_ZA |
dc.type | Article | en_ZA |